Advanced Search
- Cancer
- Chronic Diseases / Disorders
- Diabetes
- Diagnosis
- Fetal Alcohol Spectrum Disorder (FASD)
- Health Economics / Healthcare Costs
- Health Measurement Tools
- Health Policy
- Healthcare Services
- Infectious Diseases
- Maternal and Child Health
- Mental Health
- Other
- Pharmaceuticals
- Prevention
- Quality of Life
- Screening
- Surveillance
- Telehealth
- Therapy
- Brown, Jasmine
- Chojecki, Dagmara
- Corabian, Paula
- Escober-Doran, Carissa
- Guo, Bing
- Harstall, Christa
- Husereau, Don
- Institute of Health Economics, IHE
- Jacobs, Philip
- Jonsson, Egon
- Moga, Carmen
- Nguyen, Thanh
- Ohinmaa, Arto
- Scott, Ann
- Sproule, John
- Thompson, Angus
- Tjosvold, Lisa
- Waye, Arianna
- Yan, Charles
- Zheng, Yufei
Biologics and Subsequent Entry Biologics: HTA perspectives
PDF of a PowerPoint Presentation by Dr. Chander Sehgal, Director, Common Drug Review (CDR) and Optimal Use, Canadian Agency for Drugs and Technologies in Health (CADTH).
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
Event Link: Biologic and Biosimilar Therapies
Year of Publication: 2014